Quantcast

Latest Immunohistochemistry Stories

2009-04-22 17:52:00

DENVER, April 22 /PRNewswire/ -- Cambridge Research & Instrumentation, Inc. (CRi) introduced the Vectra(TM) Intelligent Slide Analysis System at the 100th Annual Meeting of the American Association for Cancer Research (AACR) in Denver.

2008-12-10 08:30:00

- May help avoid incorrect Breast Cancer diagnosis and management TORONTO, Dec. 10 /PRNewswire-FirstCall/ - Predictive medicine company PreMD Inc.

2008-10-31 09:00:28

SUNNYVALE, Calif., Oct. 31 /PRNewswire/ -- Pathwork Diagnostics, a molecular diagnostics company focused on oncology, will present three studies involving the gene expression based Pathwork(R) Tissue of Origin Test at the Association for Molecular Pathology (AMP) Annual Meeting.

2008-09-23 18:00:15

PHILADELPHIA, Sept. 23 /PRNewswire/ -- Researchers have demonstrated a new instrument that makes it possible to detect and quantify multiple clinically important proteins in a single tumor sample using conventional staining.

2008-09-16 09:00:53

Invitrogen, a provider of essential life science technologies for research, production and diagnostics, has signed an exclusive US distribution agreement with Biocare Medical, a provider of immunohistochemistry reagents, multiplex stains, and automated platforms for the anatomic pathology market, for the new Spot-Light Her2 CISH kit.

2008-09-15 18:00:37

Invitrogen Corporation, (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, has signed an exclusive U.S.

2008-09-03 09:00:07

GAITHERSBURG, Md., Sept. 3 /PRNewswire/ -- Panacea Pharmaceuticals, Inc. today announced the issuance of U.S. Patent Number 7,413,737 covering antibodies against human aspartyl (asparaginyl) beta-hydroxylase (HAAH), a proprietary human cancer biomarker and therapeutic target.

2008-08-20 09:01:30

Sigma-Aldrich has announced the addition of over 2,000 antibodies to its line of Prestige antibodies. These antibodies are developed by the Human Proteome Resource and are commercially available through an exclusive partnership with Sigma-Aldrich and Atlas Antibodies.